Opioid Use Disorder
PTSD exposure therapy does not cause drug relapse, psychiatric symptoms
Exposure therapy did not appear to increase substance use or other psychiatric symptoms among individuals with PTSD and comorbid substance use disorder, according to study results published in Journal of Traumatic Stress.
FDA requires opioid, OUD medication labels to include naloxone information
The FDA announced that drug manufacturers will now be required to include information about naloxone in prescribing information for opioids and medications to treat opioid use disorders.
Expanding methadone maintenance to pharmacies may reduce driving times, increase access
Methadone maintenance dispensed via pharmacy vs. opioid treatment programs may reduce driving times to receive this treatment in the U.S., according to results of a descriptive cross-sectional study published in JAMA Psychiatry.
Linked databases could help identify those at risk for opioid overdoses
Linked administrative databases accurately predicted fatal and nonfatal opioid overdose, according to study results published in JAMA Psychiatry.
Pharmacotherapy plus CBT should be best practice for addiction treatment, data show
Addiction treatment best practices should include pharmacotherapy plus cognitive behavioral therapy or another evidence-based therapy, according to results of a systematic review and meta-analysis published in JAMA Network Open.
Opioid use disorder medication, self-help groups rarely offered together
The National Institute on Drug Abuse states that self-help groups, “so long as they do not discourage participants from taking medications, can be particularly helpful during recovery” from opioid addiction.
Few patients receive follow-up after opioid overdose
Just 16.6% of commercially insured patients receive follow-up care after being released from the ED for a nonfatal opioid overdose, according to a study published in JAMA Network Open.
IBD pain not well controlled during hospitalization
Pain scores in patients with inflammatory bowel disease did not improve during hospitalization despite high opioid use, according to research published in Digestive Disease and Sciences.
80% of ED clinicians feel unready to initiate buprenorphine for opioid use disorder
Few ED clinicians expressed readiness to initiate buprenorphine for the treatment of opioid use disorder, according to study results published in JAMA Network Open.
Patients admitted to ED for drug overdose at increased risk for suicide
Patients admitted to EDs for nonfatal opioid or sedative/hypnotic drug overdose had “exceptionally high” risks for death due to suicide, unintentional overdose and other causes, according to results of a retrospective cohort study published in American Journal of Preventive Medicine.